Premaitha Health announced a partnership with a leading diagnostic laboratory in India to offer non-invasive prenatal screening. The NIPT technology acquired through the acquisition of Taiwanese company Yourgene in 2016 is developed on a Thermo Fisher Scientific next-generation sequecing platform. The acquisition provided Premaitha access to Yourgene's existing customers in Taiwnan, India, Thailand, Indonesia and Malaysia.
The three year NIPT agreement with an undisclosed partner will be operational by fourth quarter of 2018 with the NIPT analysis being performed at the bioinformatics center in Taiwan.
India promises to be a significant growth market for Premaitha with a population of 1.28B1 and growing at 1.17%1.
Source: Premaitha Press Release
1. Index Mundi